BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©Author(s) (or their employer(s)) 2026.
World J Gastrointest Surg. Feb 27, 2026; 18(2): 113698
Published online Feb 27, 2026. doi: 10.4240/wjgs.v18.i2.113698
Table 2 Clinical results and complications, n (%)

PD (n = 37)
EP (n = 37)
χ2
P value
Pathology
    Adenoma20 (54.05)26 (70.27)2.1570.141
    Carcinoma in situ17 (45.95)11 (29.73)
Biliary stent placement
    No36 (97.30)30 (81.08)5.0450.025
    Yes1 (2.70)7 (18.92)
Pancreatic stent placement
    No9 (24.32)7 (18.92)0.3190.572
    Yes28 (75.68)30 (81.08)
Complications
    Hemorrhage
        No31 (83.78)33 (89.19)0.4630.496
        Yes6 (16.22)4 (10.81)
    Perforation
        No35 (94.59)36 (97.30)0.3470.556
        Yes2 (5.41)1 (2.70)
    Biliary fistula
        No36 (97.30)37 (100.00)1.0140.314
        Yes1 (2.70)0 (0.00)
    Pancreatic fistula
        No32 (86.49)37 (100.00)5.3620.021
        Yes5 (13.51)0 (0.00)
    Cholangitis
        No35 (94.59)34 (91.89)0.2140.643
        Yes2 (5.41)3 (8.11)
    Pancreatitis
        No34 (91.89)34 (91.89)0.0010.999
        Yes3 (8.11)3 (8.11)
    Abdominal infection
        No29 (78.38)36 (97.30)6.1980.013
        Yes8 (21.62)1 (2.70)
    Mortality
        No35 (94.59)37 (100.00)2.0560.152
        Yes2 (5.41)0 (0.00)


Write to the Help Desk